TLR4 signal transduction pathways neutralize the effect of Fas signals on glioblastoma cell proliferation and migration

Cancer Letters

Volumn 311, Issue 2, 2011, Pages 195-202

  Sarrazy, Vincent ^a   Vedrenne, Nicolas ^a   Billet, Fabrice ^a   Bordeau, Nelly ^a   Lepreux, Sébastien ^b   Vital, Anne ^b   Jauberteau, Marie Odile ^a   Desmoulière, Alexis ^a  

^a UNIVERSITÉ DE LIMOGES   (France)

^b HÔPITAL PELLEGRIN   (France)

Author keywords

Fas; Glioblastoma; Migration; Proliferation; TLR4

Indexed keywords

CASPASE; FAS ANTIGEN; GELATINASE B; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTIGENS, CD95; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 80053132917     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.07.018     Document Type: Article

References (39)

1. Brandes A.A., Tosoni A., Franceschi E., Reni M., Gatta G., Vecht C. Glioblastoma in adults. Crit. Rev. Oncol. Hematol. 2008, 67:139-152.
2. Palanichamy K., Chakravarti A. Combining drugs and radiotherapy: from the bench to the bedside. Curr. Opin. Neurol. 2009, 22:625-632.
3. Arai H., Gordon D., Nabel E.G., Nabel G.J. Gene transfer of Fas ligand induces tumor regression in vivo. Proc. Natl Acad. Sci. USA 1997, 94:13862-13867.
4. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science 1998, 281:1305-1308.
5. Scaffidi C., Schmitz I., Zha J., Korsmeyer S.J., Krammer P.H., Peter M.E. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J. Biol. Chem. 1999, 274:22532-22538.
6. Shinohara H., Yagita H., Ikawa Y., Oyaizu N. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation. Cancer Res. 2000, 60:1766-1772.
7. Chicoine M.R., Zahner M., Won E.K., Kalra R.R., Kitamura T., Perry A., Higashikubo R. The in vivo antitumoral effects of lipopolysaccharide against glioblastoma multiforme are mediated in part by Toll-like receptor 4. Neurosurgery 2007, 60:372-380.
8. Cohen J. The immunopathogenesis of sepsis. Nature 2002, 420:885-891.
9. Barton G.M., Medzhitov R. Toll-like signaling pathways. Science 2003, 300:1524-1525.
10. Acosta-Rodríguez E.V., Craxton A., Hendricks D.W., Merino M.C., Montes C.L., Clark E.A., Gruppi A. BAFF and LPS cooperate to induce B cells to become susceptible to CD95/Fas-mediated cell death. Eur. J. Immunol. 2007, 37:990-1000.
11. Fauchais A.L., Lalloué F., Lise M.C., Boumediene A., Preud'homme J.L., Vidal E., Jauberteau M.O. Role of endogenous brain-derived neurotrophic factor and sortilin in B cell survival. J. Immunol. 2008, 181:3027-3038.
12. Bertrand J., Begaud-Grimaud G., Bessette B., Verdier M., Battu S., Jauberteau M.O. Cancer stem cells from human glioma cell line are resistant to Fas-induced apoptosis. Int. J. Oncol. 2009, 34:717-727.
13. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1984, 65:55-63.
14. Liang C.C., Park A.Y., Guan J.L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2007, 2:329-333.
15. Lee S.J., Zhou T., Choi C., Wang Z., Benveniste E.N. Differential regulation and function of Fas expression on glial cells. J. Immunol. 2000, 164:1277-1285.
16. Weller M., Frei K., Groscurth P., Krammer P.H., Yonekawa Y., Fontana A. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. J. Clin. Invest. 1994, 94:954-964.
17. Riffkin C.D., Gray A.Z., Hawkins C.J., Chow C.W., Ashley D.M. Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction. Neuro Oncol. 2001, 3:229-240.
18. Lehnardt S., Lachance C., Patrizi S., Lefebvre S., Follett P.L., Jensen F.E., Rosenberg P.A., Volpe J.J., Vartanian T. The toll-like receptor is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. 2002, 22:2478-2486.
19. Bsibsi M., Ravid R., Gveric D., van Noort J.M. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 2002, 61:1013-1021.
20. Bowman C.C., Rasley A., Tranguch S.L., Marriott I. Cultured astrocytes express toll-like receptors for bacterial products. Glia 2003, 43:281-291.
21. Carpentier P.A., Begolka W.S., Olson J.K., Elhofy A., Karpus W.J., Miller S.D. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 2005, 49:360-374.
22. Won E.K., Zahner M.C., Grant E.A., Gore P., Chicoine M.R. Analysis of the antitumoral mechanisms of lipopolysaccharide against glioblastoma multiforme. Anticancer Drugs 2003, 14:457-466.
23. Huang B., Zhao J., Li H., He K.L., Chen Y., Chen S.H., Mayer L., Unkeless J.C., Xiong H. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res. 2005, 65:5009-5014.
24. Grauer O.M., Molling J.W., Bennink E., Toonen L.W., Sutmuller R.P., Nierkens S., Adema G.J. TLR ligands in the local treatment of established intracerebral murine gliomas. J. Immunol. 2008, 181:6720-6729.
25. Schildberg F.A., Schulz S., Dombrowski F., Minor T. Cyclic AMP alleviates endoplasmic stress and programmed cell death induced by lipopolysaccharides in human endothelial cells. Cell Tissue Res. 2005, 320:91-98.
26. Sherwin C., Fern R. Acute lipopolysaccharide-mediated injury in neonatal white matter glia: role of TNF-alpha, IL-1beta, and calcium. J. Immunol. 2005, 175:155-161.
27. Chao W., Shen Y., Zhu X., Zhao H., Novikov M., Schmidt U., Rosenzweig A. Lipopolysaccharide improves cardiomyocyte survival and function after serum deprivation. J. Biol. Chem. 2005, 280:21997-22005.
28. Liu X., Chen N., Wang X., He Y., Chen X., Huang Y., Yin W., Zhou Q. Apoptosis and proliferation markers in diffusely infiltrating astrocytomas: profiling of 17 molecules. J. Neuropathol. Exp. Neurol. 2006, 65:905-913.
29. G. Eisele, M. Weller, Targeting apoptosis pathways in glioblastoma, Cancer Lett., in press (available online 26.01.11).
30. Chang D.W., Xing Z., Pan Y., Algeciras-Schimnich A., Barnhart B.C., Yaish-Ohad S., Peter M.E., Yang X. C-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 2002, 21:3704-3714.
31. Thuringer D., Hammann A., Benikhlef N., Fourmaux E., Bouchot A., Wettstein G., Solary E., Garrido C. Transactivation of the epidermal growth factor receptor by heat shock protein 90 via toll-like receptor 4 contributes to the migration of glioblastoma cells. J. Biol. Chem. 2010, 286:3418-3428.
32. Yong V.W., Krekoski C.A., Forsyth P.A., Bell R., Edwards D.R. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 1998, 21:75-80.
33. Ogier C., Creidy R., Boucraut J., Soloway P.D., Khrestchatisky M., Rivera S. Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study. BMC Neurosci. 2005, 6:68.
34. Wang M., Wang T., Liu S., Yoshida D., Teramoto A. The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades. Brain Tumor Pathol. 2003, 20:65-72.
35. Komatsu K., Nakanishi Y., Nemoto N., Hori T., Sawada T., Kobayashi M. Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas. Brain Tumor Pathol. 2004, 21:105-112.
36. Zhao J.X., Yang L.P., Wang Y.F., Qin L.P., Liu D.Q., Bai C.X., Nan X., Shi S.S., Pei X.J. Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells. Eur. J. Neurol. 2007, 14:510-516.
37. Ohashi K., Burkart V., Flohé S., Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J. Immunol. 2000, 164:558-561.
38. Smiley S.T., King J.A., Hancock W.W. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J. Immunol. 2001, 167:2887-2894.
39. Kluwe J., Mencin A., Schwabe R.F. Toll-like receptors, wound healing, and carcinogenesis. J. Mol. Med. 2009, 87:125-138.